Pharmacogenomics (PGx) Community

The Pharmacogenomics Community combines the disciplines of biochemistry, biophysics, genetics, molecular biology, bioinformatics, and pharmacology to elucidate the mechanisms of drug action, toxicity, metabolism and transport and to identify genetic determinants of variability in drug exposure, response and toxicity.

Community Goals

  • Facilitate interaction and collaboration between members of the Pharmacogenomics Community via social media and networking opportunities
  • Spur interest and growth in the area of pharmacogenomics
  • Act as the primary home for researchers in the area of pharmacogenomics
  • Support member engagement in the Precision Medicine Initiative

Join the LinkedIn Group.

Programs of Interest
University of Florida Training Program
The University of Florida announces a new training program funded by the National Institutes of Health’s National Human Genomic Research Institute. The Program for Applied Research and Development in Genomic Medicine, or PARADIGM, offers trainees mentoring from world-renowned scientists, clinical exposure in multiple areas of genomic medicine and stimulating career development opportunities within the robust, interdisciplinary research environment at UF. Learn more here.

Are you interested in volunteering within the PMG Community? Email your interest to Jason Karnes, PharmD, PhD, or update your involvement interests online.

Past Webinars
The webinars below can be accessed in the Members Only Webinar Library: Access Library
  • Cost Effectiveness for Pharmacogenetic Testing: The U-PGx Project Experience
  • Pre-Emptive Pharmacogenomic Testing Reduces the Risk of Adverse Drug Reactions by 30%: The Time for Implementation is Now
  • Interrogating Germline Genetic Variation for Pharmacogenomic Discovery, Validation, and Clinical Implementation
  • Clinical Implementation of Pharmacogenomic (PGx) Profile Service at Mayo Clinic
  • Building Bridges Between Industry, Academia, Health Care Systems and Communities to Advance Pharmacogenomics and Precision Medicine
  • Taking A Second Look: A Type 2 Diabetes Subtype Responsive to Intensive Glycemia Treatment in the ACCORD Trial
  • Pharmacogenomics Studies in Caribbean Hispanics Bridging the Gap to Reduce Healthcare Disparities
  • 2020 ASCPT-FDA William B Abrams Award Lecture: Clinical Implementation of Pharmacogenetics
  • Standardizing CYP2D6 Genotype to Phenotype Translation and Its Impact on Clinical Implementation
  • Drug Re-purposing Opportunities Using Shared Gene Expression Molecular Signatures - Case Studies in Neurodegenerative Diseases and Infections
  • Implementation of a Clinical Pharmacogenomics Service in a Pediatric Health System
  • From a Genotype to Multiple Phenotypes: Drug-Induced and Disease-Induced Phenoconversion
  • Functional Annotation of Variants of Uncertain Significance
  • The Dutch Pharmacogenetics Working Group Guidelines: Putting Pharmacogenetics into Practice
  • Drug-Drug Interactions of Gene-Drug Interactions
  • Standardizing Terms for Clinical Pharmacogenetic Test Results
  • Journal Club "Comparison of Genome Sequencing and Clinical Genotyping for Pharmacogenes"
  • Incorporating Pharmacogenetic Testing into Graduate Pharmacy Curriculum Significantly Enhances Students Knowledge and Attitude towards Personalized and Precision Medicine
  • Integration of Precision Medicine Initiative into Clinical Practice

S Singh

Sonal Singh, PharmD, PhD

Community Chair


Picture coming soon

Scott Mosley, PharmD

Community Co-Vice Chair
Picture coming soon

JJ Bhongsatiern, PhD

Community Co-Vice Chair


G Stocco

Gabriele Stocco, PharmD, PhD

Community Past Chair


Steering Committee

Nihal El Rouby, PharmD, PhD
Dan Hertz, PharmD, PhD
Jason Karnes, PharmD, PhD
Laura Ramsey, PhD
Photo Gallery
Recent News
Contact Us